How much does a box of Lorlatinib (lorlatinib) targeted drug cost? Price comparison at home and abroad and medical insurance reimbursement status
Lorlatinib (lorlatinib) is a third-generation ALK inhibitor used to treat ALK-positive non-small cell lung cancer. It has been officially launched in my country and has been included in the medical insurance catalog. Patients can purchase the drug directly at domestic hospitals or designated pharmacies, but even after reimbursement by medical insurance, the price is still relatively high. It is understood that the price of purchasing a box of Lorlatinib in China is about RMB 10,000 to 20,000. The actual out-of-pocket amount varies according to local medical insurance policies. It is recommended that patients consult the local hospital pharmacy to obtain the specific reimbursement ratio and amount.
In addition, there are also generic versions of lorlatinib (lorlatinib) from Laos and Bangladesh on the market, which are more affordable and generally range from more than 1,000 yuan to several thousand yuan. The active ingredients of these generic drugs are basically the same as those of the original drugs, and they are favored by many patients with limited economic conditions. However, when choosing to purchase overseas versions, patients need to pay attention to the formality of the channels and the authenticity of the drugs to ensure the safety of medication.
In general, lorlatinib (lorlatinib) is covered by medical insurance in China but the cost is still high, while overseas versions provide a variety of price options, especially generic drugs, which have more advantages in terms of cost performance.
Reference link: https://www.lorbrena.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)